机械辅助循环支持机构间注册登记(INTERMACS)分析:成人先天性心脏病患者接受机械循环支持后的住院、功能状态与死亡率
基于INTERMACS数据库,将128例成人先天性心脏病(ACHD)患者与512例非ACHD患者倾向性匹配,比较机械循环支持(MCS)后结局。ACHD患者MCS植入时住院时间更长(24 vs 19天,p=0.006),仅植入后前5个月死亡率显著更高(p=0.003),接受移植概率更低(p=0.003),但不良事件率、功能状态与健康相关生活质量改善相似。
要点
- ACHD患者MCS植入时住院时间较非ACHD患者更长(24 vs 19天,p=0.006)。
- ACHD患者仅MCS植入后前5个月死亡率显著更高(p=0.003),接受移植概率更低(p=0.003)。
- 两组MCS后不良事件率、功能状态及健康相关生活质量改善相似。
核心结论
- ACHD患者MCS后早期死亡率更高,但不良事件率及功能能力与生活质量改善与非ACHD患者相似。
- 这些数据支持在经选择的ACHD患者中扩大MCS的使用。
研究设计与样本
- 从INTERMACS数据库识别ACHD患者,依据INTERMACS第七年度报告的风险因素与非ACHD患者进行倾向性匹配。
- ACHD组128例,非ACHD组512例,基线特征匹配良好。
- 主要结局为MCS后死亡率,同时分析不良事件率、功能状态与健康相关生活质量。
主要发现
- ACHD患者MCS植入时住院时间较非ACHD患者更长(24 vs 19天,p=0.006)。
- ACHD患者仅MCS植入后前5个月死亡率显著更高(p=0.003)。
- ACHD患者接受移植的概率更低(p=0.003)。
- 两组MCS后不良事件率与住院率相似。
- 两组MCS后功能状态与健康相关生活质量改善相似。
临床怎么用
- 原文结论指出这些数据支持在经选择的ACHD患者中扩大MCS的使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adult congenital heart disease (ACHD) prevalence is increasing worldwide, with advanced heart failure (HF) as a leading cause of death. Limited data are available on durable mechanical circulatory support (MCS) in ACHD patients. METHODS: ACHD patients from the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) database were identified and propensity matched with non-ACHD patients using risk factors from the INTERMACS Seventh Annual Report. We compared these groups for the primary outcome of post-MCS mortality. We also investigated adverse event rates, functional status, and health-related quality of life. RESULTS: ACHD (n = 128) and non-ACHD (n = 512) patients were appropriately matched by baseline characteristics. ACHD patients had a longer length of stay at MCS implant (24 vs 19 days, p = 0.006) but similar rates of post-MCS adverse events and hospitalization. There were similar improvements in functional status and health related quality of life post-MCS in both groups. ACHD patients had significantly higher mortality post-MCS exclusively during the first 5 months after implant (p = 0.003) and a lower probability of receiving a transplant (p = 0.003). Risk factors for early mortality were biventricular or total artificial heart device implant and age > 50 years. CONCLUSIONS: ACHD patients experience a higher early mortality after MCS but have similar adverse event rates and similar improvements in functional capacity and quality of life compared with non-ACHD patients. These data support expansion of MCS use in selected ACHD patients.
引用
- Cedars A, Vanderpluym C, Koehl D, et al. An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of hospitalization, functional status, and mortality after mechanical circulatory support in adults with congenital heart disease. J Heart Lung Transplant. 2017. PMID: 29198868. doi:10.1016/j.healun.2017.11.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。